Mark Esser, an executive at Big Pharma firm AstraZeneca, has been named the inaugural leader of UVa's future Manning ...

On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy over its use of non-human primates, plunged 28 percent after the FDA issued ...

A pandemic-era upswing in life sciences investment created a lab building boom in 2021 and 2022, which has since created a supply glut, with tens of millions of square feet of brand-new, empty lab ...

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.

Cell programming biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of therapeutics development. The decision was driven by “shifting ...

The Cambridge, Massachusetts-based biotech is closing “following careful consideration of potential paths forward and strategic factors,” HC CEO and cofounder Leslie Williams said in an ...

Credit: Rocket Lab webcast WASHINGTON — Rocket Lab has completed the deployment of a constellation of Internet-of-Things satellites for French company Kinéis with a launch March 17. An Electron ...

In the cutting-edge world of biotechnology, your lab's proprietary information is its lifeblood. As such, ensuring the security of your intellectual property, research data, and trade secrets is ...

A Boston biotech try­ing to bring trans­fer RNA (tR­NA) bi­ol­o­gy to the drug de­vel­op­ment field has shut­tered op­er­a­tions, End­points News has learned.